Frequent mutations in the MITF pathway in melanoma

Pigment Cell and Melanoma Research

Volumn 22, Issue 4, 2009, Pages 435-444

  Cronin, Julia C ^a   Wunderlich, John ^b   Loftus, Stacie K ^a   Prickett, Todd D ^a   Wei, Xiaomu ^a   Ridd, Katie ^c   Vemula, Swapna ^c   Burrell, Allison S ^a   Agrawal, Neena S ^a   Lin, Jimmy C ^d   Banister, Carolyn E ^e   Buckhaults, Phillip ^e   Rosenberg, Steven A ^b   Bastian, Boris C ^c   Pavan, William J ^a   Samuels, Yardena ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

5 7 MITF; Melanoma; Mutations; P21; Sequencing; SOX10

Indexed keywords

HELIX LOOP HELIX PROTEIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX10;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE DISRUPTION; GENE MUTATION; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTE; MELANOMA; MELANOMAGENESIS; METASTASIS; MITF GENE; MOUSE; NONHUMAN; NONSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE; PROTEIN DNA BINDING; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SKIN CARCINOGENESIS; SOX10 GENE; TRANSACTIVATION;

CELL LINE, TUMOR; CODON, NONSENSE; FRAMESHIFT MUTATION; GENES, RAS; HUMANS; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MUTATION; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS; SOXE TRANSCRIPTION FACTORS;

EID: 67749122578     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00578.x     Document Type: Article

References (34)

1. Bentley, N.J., Eisen, T. Goding, C.R. (1994). Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol. 14, 7996 8006.
2. Bismuth, K., Maric, D. Arnheiter, H. (2005). MITF and cell proliferation: the role of alternative splice forms. Pigment Cell Res. 18, 349 359.
3. Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E., Le Caignec, C., Wegner, M. Goossens, M. (2000). Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet. 9, 1907 1917.
4. Carreira, S., Goodall, J., Aksan, I., La Rocca, S.A., Galibert, M.D., Denat, L., Larue, L. Goding, C.R. (2005). Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 433, 764 769.
5. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L. Goding, C.R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426 3439.
6. Chappell, D.B., Zaks, T.Z., Rosenberg, S.A. Restifo, N.P. (1999). Human melanoma cells do not express Fas (Apo-1/CD95) ligand. Cancer Res. 59, 59 62.
7. Curtin, J.A., Fridlyand, J., Kageshita, T. et al. (2005). Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135 2147.
8. Davies, H., Bignell, G.R., Cox, C. et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949 954.
9. Demunter, A., Stas, M., Degreef, H., De Wolf-Peeters, C. Van Den Oord, J.J. (2001). Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J. Invest. Dermatol. 117, 1483 1489.
10. Garraway, L.A., Widlund, H.R., Rubin, M.A. et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117 122.
11. Hallsson, J.H., Favor, J., Hodgkinson, C. et al. (2000). Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus. Genetics 155, 291 300.
12. Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290 302.
13. Hou, L. Pavan, W.J. (2008). Transcriptional and signaling regulation in neural crest stem cell-derived melanocyte development: do all roads lead to Mitf? Cell Res. 18, 1163 1176.
14. Jiao, Z., Mollaaghababa, R., Pavan, W.J., Antonellis, A., Green, E.D. Hornyak, T.J. (2004). Direct interaction of Sox10 with the promoter of murine Dopachrome Tautomerase (Dct) and synergistic activation of Dct expression with Mitf. Pigment Cell Res. 17, 352 362.
15. Khong, H.T. Rosenberg, S.A. (2002). The Waardenburg syndrome type 4 gene, SOX10, is a novel tumor-associated antigen identified in a patient with a dramatic response to immunotherapy. Cancer Res. 62, 3020 3023.
16. Lee, M., Goodall, J., Verastegui, C., Ballotti, R. Goding, C.R. (2000). Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J. Biol. Chem. 275, 37978 37983.
17. Levy, C., Khaled, M. Fisher, D.E. (2006). MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12, 406 414.
18. Loercher, A.E., Tank, E.M., Delston, R.B. Harbour, J.W. (2005). MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J. Cell Biol. 168, 35 40.
19. Loftus, S.K., Larson, D.M., Watkins-Chow, D., Church, D.M. Pavan, W.J. (2001). Generation of RCAS vectors useful for functional genomic analyses. DNA Res. 8, 221 226.
20. Ludwig, A., Rehberg, S. Wegner, M. (2004). Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors. FEBS Lett. 556, 236 244.
21. Murisier, F., Guichard, S. Beermann, F. (2007). The tyrosinase enhancer is activated by Sox10 and Mitf in mouse melanocytes. Pigment Cell Res. 20, 173 184.
22. Omholt, K., Karsberg, S., Platz, A., Kanter, L., Ringborg, U. Hansson, J. (2002). Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression. Clin. Cancer Res. 8, 3468 3474.
23. Omholt, K., Platz, A., Kanter, L., Ringborg, U. Hansson, J. (2003). NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin. Cancer Res. 9, 6483 6488.
24. Potterf, S.B., Furumura, M., Dunn, K.J., Arnheiter, H. Pavan, W.J. (2000). Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum. Genet. 107, 1 6.
25. Potterf, S.B., Mollaaghababa, R., Hou, L., Southard-Smith, E.M., Hornyak, T.J., Arnheiter, H. Pavan, W.J. (2001). Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev. Biol. 237, 245 257.
26. Ryu, B., Kim, D.S., Deluca, A.M. Alani, R.M. (2007). Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS ONE 2, e594.
27. Samuels, Y., Diaz Jr., L.A., Schmidt-Kittler, O. et al. (2005). Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561 573.
28. Steingrimsson, E., Nii, A., Fisher, D.E., Ferre-D'amare, A.R., Mccormick, R.J., Russell, L.B., Burley, S.K., Ward, J.M., Jenkins, N.A. Copeland, N.G. (1996). The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization. EMBO J. 15, 6280 6289.
29. Steingrimsson, E., Copeland, N.G. Jenkins, N.A. (2004). Melanocytes and the microphthalmia transcription factor network. Annu. Rev. Genet. 38, 365 411.
30. Sudbeck, P. Scherer, G. (1997). Two independent nuclear localization signals are present in the DNA-binding high-mobility group domains of SRY and SOX9. J. Biol. Chem. 272, 27848 27852.
31. Verastegui, C., Bille, K., Ortonne, J.P. Ballotti, R. (2000). Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J. Biol. Chem. 275, 30757 30760.
32. White, R.M. Zon, L.I. (2008). Melanocytes in development, regeneration, and cancer. Cell Stem Cell 3, 242 252.
33. Wu, M., Hemesath, T.J., Takemoto, C.M., Horstmann, M.A., Wells, A.G., Price, E.R., Fisher, D.Z. Fisher, D.E. (2000). c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14, 301 312.
34. Xu, W., Gong, L., Haddad, M.M., Bischof, O., Campisi, J., Yeh, E.T. Medrano, E.E. (2000). Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp. Cell Res. 255, 135 143.